Glaser Pediatric Research Network
Hasten the transfer of research findings into patient treatment and therapies geared expressly for, and tested on, children.
Diagnostic and therapeutic guidelines used for children are commonly extrapolated from studies conducted in adults. There are potential dangers in assuming that children will have the same response to disease or therapy as adults, given important physiological differences. Currently, 70% of drugs prescribed for children in the U.S have not been tested specifically in children. The network's mission is to conduct clinical trials with both speed and excellence on behalf of children's health.
Advocate public policy to improve children's health here and around the world.
The Network addresses long-term pediatric issues in the legislative process and in the pharmaceutical and biomedical corporate environment to ensure that children remain a priority.
Train the next generation of pediatric clinical investigators, thereby ensuring children the latest medical treatments.
Pediatric research continues to be under-emphasized, and children with life-threatening diseases often do not receive the benefits of new technologies and treatments because of impediments to clinical research on children including the dwindling number of doctors entering into pediatric research.